XML 29 R18.htm IDEA: XBRL DOCUMENT
v3.24.1.u1

Segment Information | 9 Months Ended
--- | ---
Mar. 31, 2024
Notes to Financial Statements |
Segment Information | Note 13. Segment Information: The Company's management evaluates segment operating performance based on operating income before certain charges to cost of sales and selling, general and administrative expenses, principally associated with the impact of partially-owned consolidated subsidiaries as well as acquisition accounting related to inventory, amortization of acquisition-related intangible assets and other acquisition-related expenses. The Protein Sciences and Diagnostics and Genomics segments both include consumables, instruments, services and royalty revenue. The following is financial information relating to the Company's reportable segments (in thousands): ​
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | Quarter Ended | ​ | Nine Months Ended
​ | ​ | March 31, | ​ | March 31,
​ |  | 2024 |  | 2023 | ​ | 2024 |  | 2023
Net sales: |  | ​ |  | ​ | ​ | ​ | ​ | ​ |  | ​ | ​ | ​
Protein Sciences | ​ | $ | 214,589 |  | $ | 218,903 | ​ | $ | 616,914 |  | $ | 622,739
Diagnostics and Genomics | ​ |  | 87,511 | ​ |  | 75,669 | ​ |  | 235,715 | ​ |  | 213,577
Other revenue(1) | ​ | ​ | 2,093 | ​ | ​ | — | ​ | ​ | 2,093 | ​ | ​ | —
Intersegment | ​ |  | (765) | ​ |  | (426) | ​ |  | (1,761) | ​ |  | (934)
Consolidated net sales | ​ | $ | 303,428 |  | $ | 294,146 | ​ | $ | 852,961 |  | $ | 835,382
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
Operating income: | ​ |  |  | ​ |  |  | ​ |  |  | ​ |  |
Protein Sciences | ​ | $ | 94,829 |  | $ | 98,756 | ​ | $ | 262,777 |  | $ | 274,035
Diagnostics and Genomics | ​ |  | 8,104 | ​ |  | 11,464 | ​ |  | 13,189 | ​ |  | 28,399
Segment operating income | ​ | $ | 102,933 | ​ | $ | 110,220 | ​ | $ | 275,966 | ​ | $ | 302,434
Costs recognized on sale of acquired inventory | ​ |  | (186) | ​ |  | — | ​ |  | (550) | ​ |  | (400)
Amortization of intangibles | ​ |  | (19,287) | ​ |  | (19,286) | ​ |  | (58,908) | ​ |  | (57,694)
Impact of partially-owned consolidated subsidiaries(2) | ​ |  | — | ​ |  | — | ​ |  | — | ​ |  | 647
Acquisition related expenses and other | ​ |  | (3,286) | ​ |  | 1,333 | ​ |  | (2,173) | ​ |  | 9,343
Impairment of assets held-for-sale | ​ | ​ | — | ​ | ​ | — | ​ | ​ | (6,038) | ​ | ​ | —
Stock based compensation, inclusive of employer taxes | ​ |  | (8,358) | ​ |  | (10,543) | ​ |  | (32,810) | ​ |  | (42,879)
Restructuring and restructuring-related costs | ​ |  | (1,550) | ​ |  | — | ​ |  | (7,157) | ​ |  | (2,950)
Corporate general, selling, and administrative expenses | ​ |  | (3,346) | ​ |  | (1,513) | ​ |  | (7,545) | ​ |  | (4,082)
Impact of business held-for-sale(1) | ​ | ​ | 78 | ​ | ​ | — | ​ | ​ | 78 | ​ | ​ | —
Consolidated operating income | ​ | $ | 66,998 |  | $ | 80,211 | ​ | $ | 160,863 |  | $ | 204,419
(1) Includes the quarterly results of a business that has met the held-for-sale criteria since December 31, 2023. (2) Includes the quarterly results of the partially-owned consolidated subsidiary prior to the sale of this partially-owned consolidated subsidiary to a third party in the first fiscal quarter of 2023.

X
- References No definition available. + Details
Name: | us-gaap_DisclosureTextBlockAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 22 -Publisher FASB -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 15 -Publisher FASB -URI https://asc.fasb.org//1943274/2147482810/280-10-50-15 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 31 -Publisher FASB -URI https://asc.fasb.org//1943274/2147482810/280-10-50-31 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 32 -Subparagraph (d) -Publisher FASB -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32 Reference 5: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 42 -Publisher FASB -URI https://asc.fasb.org//1943274/2147482810/280-10-50-42 Reference 6: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 32 -Subparagraph (f) -Publisher FASB -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32 Reference 7: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 40 -Publisher FASB -URI https://asc.fasb.org//1943274/2147482810/280-10-50-40 Reference 8: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -Name Accounting Standards Codification -Publisher FASB -URI https://asc.fasb.org//280/tableOfContent Reference 9: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 26 -Publisher FASB -URI https://asc.fasb.org//1943274/2147482810/280-10-50-26 Reference 10: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 34 -Publisher FASB -URI https://asc.fasb.org//1943274/2147482810/280-10-50-34 Reference 11: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 41 -Publisher FASB -URI https://asc.fasb.org//1943274/2147482810/280-10-50-41 Reference 12: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 21 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org//1943274/2147482810/280-10-50-21 Reference 13: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 21 -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org//1943274/2147482810/280-10-50-21 Reference 14: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 32 -Subparagraph (e) -Publisher FASB -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32 + Details
Name: | us-gaap_SegmentReportingDisclosureTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration